Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration

March 2025 in “ Journal of Clinical Medicine ”

Andrea Pagani, Dominik Thor, Adriana C. Panayi, S. Klein, Sebastian Geis, Leonard Knoedler, Samuel Knoedler, Filippo Andrea Giovanni Perozzo, Giuseppe Sofo, Rafael Loucas, Lukas Prantl, Dominik Duscher

iron chelators deferoxamine deferiprone hypoxia-inducible factor 1-alpha HIF-1α vascularization cellular proliferation hair follicles alopecia oxidative damage inflammatory responses Janus kinase inhibitors JAK inhibitors DFO DFP

TLDR Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

The article explores the use of iron chelators, such as deferoxamine (DFO) and deferiprone (DFP), in treating autoimmune-induced alopecia by stabilizing hypoxia-inducible factor 1-alpha (HIF-1α). This stabilization enhances vascularization and cellular proliferation in hair follicles, leading to improved hair density, thickness, and elasticity, and reducing hair loss by up to 66.8% over six to nine months. Iron chelators also mitigate oxidative damage and modulate inflammatory responses, offering a promising new treatment for alopecia. The therapy is safe and well-tolerated, with potential benefits when combined with immune-modulating therapies like Janus kinase (JAK) inhibitors. Future research should focus on large-scale trials and personalized approaches to maximize the effectiveness of iron chelation therapy.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

research Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways

3 citations , July 2023 in “International journal of molecular sciences”

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

research Janus Kinase Inhibitors For Alopecia Areata

12 citations , June 2023 in “JAMA network open”

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

research A Novel Hair Restoration Technology Counteracts Androgenic Hair Loss and Promotes Hair Growth in a Blinded Clinical Trial

1 citations , January 2023 in “Journal of Clinical Medicine”

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis

Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration

Research cited in this study

research Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways

research Janus Kinase Inhibitors For Alopecia Areata

research A Novel Hair Restoration Technology Counteracts Androgenic Hair Loss and Promotes Hair Growth in a Blinded Clinical Trial

research Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis

research Two Phase 3 Trials of Baricitinib for Alopecia Areata

research The JAK/STAT Signaling Pathway: From Bench to Clinic